• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒诱导的蛋白磷酸酶2A过表达抑制丙型肝炎中的胰岛素信号传导。

Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.

作者信息

Bernsmeier Christine, Duong Francois H T, Christen Verena, Pugnale Paolo, Negro Francesco, Terracciano Luigi, Heim Markus H

机构信息

Department of Biomedicine, Division of Gastroenterology and Hepatology, University Hospital Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland.

出版信息

J Hepatol. 2008 Sep;49(3):429-40. doi: 10.1016/j.jhep.2008.04.007. Epub 2008 Apr 30.

DOI:10.1016/j.jhep.2008.04.007
PMID:18486982
Abstract

BACKGROUND/AIMS: Hepatitis C virus (HCV) infection disturbs glucose and lipid metabolism contributing to the development of liver steatosis, insulin resistance and type 2 diabetes mellitus. On the other hand, insulin resistance and steatosis have been found to be associated with increased rates of fibrosis progression and lower rates of response to interferon therapy in chronic hepatitis C (CHC). The molecular mechanisms contributing to insulin resistance in CHC are not well understood. We have shown previously that protein phosphatase 2A (PP2A) is over-expressed in biopsies from patients with CHC. In this study, we tested if PP2A over-expression leads to insulin resistance.

METHODS

We studied insulin signalling in cell lines that allow the regulated over-expression of HCV proteins and of the PP2A catalytic subunit (PP2Ac). Insulin signalling and PP2Ac expression were also studied in HCV transgenic mice and in liver biopsies from patients with CHC.

RESULTS

Over-expression of PP2Ac in cells inhibited insulin signalling by dephosphorylation of PKB/Akt. PP2Ac over-expression and impaired insulin signalling were found in the liver of HCV transgenic mice and in liver biopsies of patients with CHC.

CONCLUSIONS

HCV-induced over-expression of PP2A in the liver contributes to the pathogenesis of insulin resistance in patients with CHC.

摘要

背景/目的:丙型肝炎病毒(HCV)感染会扰乱葡萄糖和脂质代谢,促使肝脂肪变性、胰岛素抵抗和2型糖尿病的发生。另一方面,已发现胰岛素抵抗和脂肪变性与慢性丙型肝炎(CHC)患者的纤维化进展加快及干扰素治疗反应率降低有关。CHC中导致胰岛素抵抗的分子机制尚未完全明确。我们之前已表明,蛋白磷酸酶2A(PP2A)在CHC患者的活检组织中过度表达。在本研究中,我们检测了PP2A的过度表达是否会导致胰岛素抵抗。

方法

我们在能够调控HCV蛋白和PP2A催化亚基(PP2Ac)过度表达的细胞系中研究胰岛素信号传导。还在HCV转基因小鼠和CHC患者的肝活检组织中研究了胰岛素信号传导和PP2Ac表达。

结果

细胞中PP2Ac的过度表达通过使蛋白激酶B/蛋白激酶B(PKB/Akt)去磷酸化而抑制胰岛素信号传导。在HCV转基因小鼠的肝脏和CHC患者的肝活检组织中发现了PP2Ac的过度表达及胰岛素信号传导受损。

结论

HCV诱导的肝脏中PP2A过度表达促成了CHC患者胰岛素抵抗的发病机制。

相似文献

1
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.病毒诱导的蛋白磷酸酶2A过表达抑制丙型肝炎中的胰岛素信号传导。
J Hepatol. 2008 Sep;49(3):429-40. doi: 10.1016/j.jhep.2008.04.007. Epub 2008 Apr 30.
2
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.慢性丙型肝炎中的胰岛素抵抗:与1型和4型基因型、血清丙型肝炎病毒RNA水平及肝纤维化的关系
Gastroenterology. 2008 Feb;134(2):416-23. doi: 10.1053/j.gastro.2007.11.010. Epub 2007 Nov 12.
3
Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression.丙型肝炎核心蛋白损害胰岛素下游信号转导和 IGFBP-1 表达的调节作用。
J Viral Hepat. 2012 Jan;19(1):65-71. doi: 10.1111/j.1365-2893.2011.01447.x. Epub 2011 May 9.
4
Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.肝胰岛素抵抗与非酒精性脂肪性肝炎和慢性丙型肝炎中的细胞凋亡和纤维化增加有关。
J Hepatol. 2011 Jan;54(1):142-52. doi: 10.1016/j.jhep.2010.06.021. Epub 2010 Aug 27.
5
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.胰岛素抵抗和糖尿病会增加1型丙型肝炎病毒感染患者肝脏的纤维化程度。
Am J Gastroenterol. 2008 May;103(5):1136-44. doi: 10.1111/j.1572-0241.2008.01813.x.
6
Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.丙型肝炎病毒感染患者中,控制干扰素介导信号传导的蛋白质的肝脏表达作为治疗反应的预测因素。
J Pathol. 2007 Nov;213(3):347-55. doi: 10.1002/path.2214.
7
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.慢性丙型肝炎患者的高丙型肝炎病毒载量与胰岛素抵抗相关。
Liver Int. 2008 Feb;28(2):271-7. doi: 10.1111/j.1478-3231.2007.01626.x. Epub 2007 Nov 19.
8
Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein.PA28γ依赖性途径参与丙型肝炎病毒核心蛋白诱导的胰岛素抵抗。
J Virol. 2007 Feb;81(4):1727-35. doi: 10.1128/JVI.01683-06. Epub 2006 Nov 29.
9
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.蛋白磷酸酶 2A 通过抑制 p53 促进二乙基亚硝胺诱导的肝癌发生。
Carcinogenesis. 2014 Jan;35(1):114-22. doi: 10.1093/carcin/bgt258. Epub 2013 Jul 29.
10
Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1.丙型肝炎病毒通过涉及诱导 PGC1α 和 FoxO1 去磷酸化的双重机制来扰乱葡萄糖稳态。
J Viral Hepat. 2014 Jan;21(1):9-18. doi: 10.1111/jvh.12208. Epub 2013 Nov 6.

引用本文的文献

1
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions.病毒性肝炎向肝细胞癌的恶性转化:机制与干预措施
MedComm (2020). 2025 Mar 8;6(3):e70121. doi: 10.1002/mco2.70121. eCollection 2025 Mar.
2
Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults.丙型肝炎感染并非年轻成年人的心血管危险因素。
Biomedicines. 2024 Oct 20;12(10):2400. doi: 10.3390/biomedicines12102400.
3
The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection.表观遗传机制在丙型肝炎感染发病机制中的作用。
Biomolecules. 2024 Aug 10;14(8):986. doi: 10.3390/biom14080986.
4
Targeting Protein Phosphatases for the Treatment of Chronic Liver Disease.靶向蛋白磷酸酶治疗慢性肝病
Curr Drug Targets. 2024;25(3):171-189. doi: 10.2174/0113894501278886231221092522.
5
Targeting ER stress/PKA/GSK-3β/β-catenin pathway as a potential novel strategy for hepatitis C virus-infected patients.针对 ER 应激/PKA/GSK-3β/β-catenin 通路作为丙型肝炎病毒感染患者的一种潜在新策略。
Cell Commun Signal. 2023 May 8;21(1):102. doi: 10.1186/s12964-023-01081-9.
6
The HCV Envelope Glycoprotein Down-Modulates NF-κB Signalling and Associates With Stimulation of the Host Endoplasmic Reticulum Stress Pathway.HCV 包膜糖蛋白下调 NF-κB 信号通路并与宿主内质网应激途径的激活相关。
Front Immunol. 2022 Mar 15;13:831695. doi: 10.3389/fimmu.2022.831695. eCollection 2022.
7
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.S-腺苷甲硫氨酸:从发现其抑制肿瘤发生到用作治疗剂。
Cells. 2022 Jan 25;11(3):409. doi: 10.3390/cells11030409.
8
HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.丙型肝炎病毒基因型对糖尿病发病率无影响——EpiTer多中心研究
J Clin Med. 2022 Jan 13;11(2):379. doi: 10.3390/jcm11020379.
9
Porcine reproductive and respiratory syndrome virus nsp4 positively regulates cellular cholesterol to inhibit type I interferon production.猪繁殖与呼吸综合征病毒 nsp4 正向调控细胞胆固醇以抑制 I 型干扰素的产生。
Redox Biol. 2022 Feb;49:102207. doi: 10.1016/j.redox.2021.102207. Epub 2021 Dec 8.
10
Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis.重编宿主信号:丙型肝炎病毒在肝脏发病机制中的作用。
Cold Spring Harb Perspect Med. 2020 Jan 2;10(1):a037366. doi: 10.1101/cshperspect.a037366.